Strategies and Problems of Pharmaceutical Industry Development in the Context of an Increased State Regulation
- DOI
- 10.2991/ahsr.k.201001.046How to use a DOI?
- Keywords
- pharmaceutical industry, health care, state regulation, R&D investment
- Abstract
Transition to a new technological mode not only leads to the emergence of new opportunities and directions of industrial development, but also causes the need for the formation of new innovative ways of production and commercial activities, the creation of new forms and technologies of enterprise management. The choice of strategy for the development of Russian pharmaceuticals in a new industrialization is complicated by the specifics of the industry. On the one hand, pharmaceutical companies, as a part of the health care system, are uniquely valuable for society and carry an extremely important mission. Innovative medicines developed today, without exaggeration, can change the future of mankind. On the other hand, the production and circulation of pharmaceutical products in Russia is under strict control of the state. The strengthening of state regulation artificially restricts the use of innovative sales technologies and non-traditional sales channels. This leads to a systematic and long-term decline in profitability, which negatively affects the investment attractiveness of the industry.
- Copyright
- © 2020, the Authors. Published by Atlantis Press.
- Open Access
- This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
Cite this article
TY - CONF AU - L.A. Ashikhina AU - N.V. Lisichkina AU - L.S. Bolshakova AU - Ju.G. Goloktionova AU - E.V. Izvekova AU - A.V. Kuzina AU - O.L. Ladnova AU - E.G. Merkulova PY - 2020 DA - 2020/10/03 TI - Strategies and Problems of Pharmaceutical Industry Development in the Context of an Increased State Regulation BT - Proceedings of the International Conference “Health and wellbeing in modern society” (ICHW 2020) PB - Atlantis Press SP - 229 EP - 232 SN - 2468-5739 UR - https://doi.org/10.2991/ahsr.k.201001.046 DO - 10.2991/ahsr.k.201001.046 ID - Ashikhina2020 ER -